Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q3 2019 · 10-Q
Revenue$8.22M$8.22M+4.5% vs Q3 2018 Net Income$1.12M$1.12M+355.6% vs Q3 2018 EPS Diluted$0.13$0.13+333.3% vs Q3 2018 Operating Income$1,993,081+116.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,690,201+3.0% Margins · derivedOperating margin24.2%+12.5 pt vs Q3 2018
Net margin13.6%+10.5 pt vs Q3 2018
ended Aug 31, 2019 · filed Oct 15, 2019 · 45 d after period end